ddp4 and glp 1 together Neuroprotection by dipeptidyl-peptidase-4 inhibitors glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Insight into Structure Activity Relationship – Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin

Withdrawal: Remove needle at the same angle it entered

GLP-1 medications are not insulin replacements and are not licensed for type 1 diabetes or diabetic ketoacidosis

Additionally, cost and insurance access play critical roles in determining which medications patients can obtain consistently

IGF-1 LR3: Highest risk for muscle building Why it's risky: Severe hypoglycemia possible Organ growth concerns with extended use Difficult to manage No long-term human safety data Can affect facial structure/jaw Risk profile: Must carry fast carbs during training Requires aggressive cycling (4-6 weeks max) Expensive Difficult to source quality product Who might use despite risks: Professional bodybuilders Advanced users with medical monitoring Short-term goals (competition prep) Safer alternatives: CJC-1295 + Ipamorelin for steady GH increase GHRP-6 if willing to accept moderate risk Natural training with safe peptides See HGH alternatives for safer growth hormone options